Perfusion Blog

A collection of posts from our Perfusion Community.

Patient In Bed

Drastic Fluctuations in CABG Costs Across Hospitals

Drastic Fluctuations in CABG Costs Across Hospitals The price of coronary artery bypass grafting (CABG) varies widely across U.S. hospitals, according to a study published in the April 1 issue of The American Journal of Cardiology. Bria D. Giacomino, DO, from the University of Iowa Carver College of Medicine in Iowa City, and colleagues obtained [...]
Read More
healthcare_costs

ECMO systems market projected to reach 287.6 million dollars by 2020 according to new research report

Extracorporeal membrane oxygenation (ECMO) systems market growing at 4.0% rate and projected to reach 287.6 million dollars by 2020 according to new research report Global extracorporeal membrane oxygenation (ECMO) system market report purpose is to cover the definition, description, and forecast. It involves deep dive analysis of market segmentation which comprises of submarkets, modality and [...]
Read More
FX25 OXYGENATOR

Terumo CV Group introduces new addition to CAPIOX Oxygenator portfolio

Terumo Cardiovascular Group (Terumo CV Group) introduces the newest addition to the CAPIOX® Oxygenator portfolio – the CAPIOX FX Advance Oxygenator. The CAPIOX FX Advance replaces the current CAPIOX FX15 and FX25 line of oxygenators manufactured in Elkton, Maryland. "Terumo Cardiovascular Group was the first company to introduce a hollow fiber membrane oxygenator and since [...]
Read More
CABG PROCEDURE

Pre-operative aspirin not linked with improved outcomes during CABG

High-risk patients undergoing coronary artery bypass graft (CABG) surgery who were randomized to receive 100mg aspirin on the day of surgery did not experience lower rates of death or thrombotic complications within 30 days after surgery compared to those who received placebo. Patients in the aspirin group did not experience higher rates of [...]
Read More
HEMOVENT ECMO

Hemovent is developing the world’s smallest and first self-contained and fully portable ECMO system

Hemovent Raises $6 Million in Series A Funding February 10, 2016 09:55 AM Eastern Standard Time AACHEN, Germany--(BUSINESS WIRE)--Hemovent GmbH, an emerging medical device company, announced today that it has closed a $6 million Series A investment. Hemovent is developing the world’s smallest and first self-contained and fully portable Extra Corporeal Membrane Oxygenation (ECMO) system [...]
Read More
Cardiohelp

Mobile ECMO- Extending reach and expertise beyond hospital walls

For very sick children in rural communities, access to care can mean a decision between a long, dangerous trip to a far-away hospital or less-sophisticated care in their local facility. Seattle Children's has just invested in technology to make that decision easier for the families who face it. Seattle Children's Hospital staff testing one of [...]
Read More